Bjørn Tore Gjertsen Selected Research

Human Papillomavirus Recombinant Vaccine nonavalent

1/2022

Thrombosis and thrombocytopenia after HPV vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bjørn Tore Gjertsen Research Topics

Disease

47	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 06/2002
41	Neoplasms (Cancer) 07/2022 - 07/2003
16	Leukemia 07/2019 - 06/2002
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 06/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 02/2014
3	Adenocarcinoma 10/2017 - 02/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 04/2013
3	Cytopenia 07/2010 - 06/2002
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
2	Circulating Neoplastic Cells 04/2021 - 09/2020
2	Inflammation (Inflammations) 01/2021 - 04/2010
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2013
2	Philadelphia Chromosome 01/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 11/2019 - 01/2010
2	Glioblastoma (Glioblastoma Multiforme) 10/2019 - 01/2019
2	Genetic Translocation (Chromosomal Translocation) 01/2018 - 12/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 12/2012
2	Ovarian Epithelial Carcinoma 01/2016 - 01/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2013 - 03/2011
2	Lymphopenia (Lymphocytopenia) 01/2010 - 12/2008
2	Chromosome Aberrations (Chromosome Abnormalities) 05/2006 - 02/2002
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2006 - 02/2006
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021
1	Premature Aging 01/2021
1	Multiple Sclerosis 01/2021
1	Pneumonia (Pneumonitis) 06/2019
1	Hypersensitivity (Allergy) 06/2019
1	Aggressive Fibromatosis (Desmoid) 06/2019
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2018

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
10	Valproic Acid (Depakote)FDA LinkGeneric 10/2019 - 01/2006
9	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2019 - 01/2006
8	CytokinesIBA 06/2019 - 02/2005
6	Histone Deacetylase InhibitorsIBA 01/2016 - 06/2006
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 06/2006
4	AntibodiesIBA 01/2022 - 09/2007
4	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2006
4	ChemokinesIBA 06/2019 - 03/2007
4	AntigensIBA 01/2019 - 09/2007
4	Phosphotransferases (Kinase)IBA 01/2018 - 02/2006
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 02/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
3	Gemcitabine FDA Link 02/2020 - 02/2014
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2006
3	Proteasome InhibitorsIBA 01/2019 - 06/2006
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 02/2006
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2014 - 02/2009
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2014 - 02/2006
2	Biological ProductsIBA 12/2020 - 03/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 06/2006
2	nilotinib FDA Link 01/2020 - 01/2017
2	InterferonsIBA 01/2020 - 06/2019
2	Trinitrotoluene (TNT)IBA 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2012
2	Bortezomib (Velcade)FDA Link 10/2019 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 03/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 07/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 01/2014
2	Histones (Histone)IBA 05/2014 - 01/2012
2	Pharmaceutical PreparationsIBA 02/2014 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 04/2010 - 01/2010
2	3-ingenyl angelateIBA 01/2010 - 06/2007
2	Protein Kinase CIBA 01/2010 - 06/2007
2	Complementary DNA (cDNA)IBA 03/2009 - 05/2006
2	Interleukin-8 (Interleukin 8)IBA 02/2005 - 04/2004
1	VaccinesIBA 01/2022
1	Human Papillomavirus Recombinant Vaccine nonavalentIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Circulating Tumor DNAIBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	Codon (Codons)IBA 01/2021
1	ProteomeIBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	Plant ExtractsIBA 12/2020
1	AnnexinsIBA 11/2020
1	Coloring Agents (Dyes)IBA 11/2020
1	fluorexon (calcein)IBA 11/2020
1	Epithelial Cell Adhesion MoleculeIBA 09/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	bosutinibIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 11/2019
1	Temozolomide (Temodar)FDA LinkGeneric 10/2019
1	Interferon-alpha (Interferon Alfa)IBA 07/2019
1	LTX-315IBA 06/2019
1	Peptides (Polypeptides)IBA 06/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018

Therapy/Procedure

32	Therapeutics 01/2022 - 04/2004
18	Drug Therapy (Chemotherapy) 01/2021 - 06/2002
6	Immunotherapy 06/2019 - 02/2006
3	Microbubbles 02/2020 - 12/2016
3	Stem Cell Transplantation 01/2018 - 06/2006
3	Aftercare (After-Treatment) 07/2010 - 02/2002
2	Precision Medicine 07/2022 - 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Lab-On-A-Chip Devices 09/2020
1	Injections 06/2019
1	Subcutaneous Injections 06/2019